Transplant Infectious Disease

Article	Citations
Disseminated nontuberculous mycobacterial infection prior to hematopoietic stem cell transplantation: A case of successful treatment	89
Gut microbiota trajectory in β‐thalassemia major children who underwent allogeneic hematopoietic stem cell transplantation	51
Cytomegalovirus events in high‐risk allogeneic hematopoietic‐cell transplantation patients who received letermovir prophylaxis	49
Parvovirus B19 in stem cell transplantation	49
Role of Fiberoptic Bronchoscopy in Decision‐Making in the Management of Post‐Hematopoietic Stem Cell Transplant Patients Presenting with Pulmonary Infiltrates: A Retrospective Cohort Study	46
Crusted Scabies with Facial Involvement in a Patient Following Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report	43
Delabeling penicillin and other antibiotic allergies in solid organ transplantation patients	37
Successful treatment of Rhodococcus lung abscess and empyema thoracis in a heart transplant recipient	35
Machine learning, antimicrobial stewardship, and solid organ transplantation: Is this the future?	35
Clinical course of human monkeypox infection in a renal transplant recipient living with human immunodeficiency virus	32
Conversion from cytomegalovirus universal prophylaxis with valganciclovir to the preemptive monitoring approach to manage leukopenia after kidney or pancreas transplantation	27
Complex considerations – Fever and pancytopenia after solid organ transplantation	26
Donor blood cultures and outcomes after lung transplantation: a single‐center report	26
	26
Re: Universal Multiplex Panel Testing of Donor Lungs as a Strategy to Optimize Antibiotic Prophylaxis against Multidrug‐Resistant Bacteria	26
Biofire pneumonia panel in lung donors: faster detection but limited pathogens	25
Clinical characteristics and outcomes in CMV infection in intestinal transplant recipients: A single‐center experience	25
Recipient and kidney graft outcomes of deceased donors with human immunodeficiency virus in the United States	24
Cryptococcal myositis and monoarthritis in a failed renal allograft recipient	23
COVID‐19 in lung transplant recipients: A single‐center experience	22
Effect of steroid pulses in severe BK virus allograft nephropathy with extensive interstitial inflammation	22
Outpatient and peri‐operative antibiotic stewardship in solid organ transplantation	21
Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation	20
Current state of antimicrobial stewardship and organ transplantation in Saudi Arabia	20
The role of alternative regimens in the management of tuberculosis in transplant recipients: From past challenges to future opportunities	20

Japan perspective on antimicrobial stewardship and solid organ transplantation	20
Utility of microbiologic testing in surveillance bronchoscopy following lung transplantation: A retrospective cohort study	19
Uncovering hidden sources of SARS‐CoV‐2 viral evolution: A call to action	19
Thank you for our 2022 reviewers	18
Comparative analysis and trends in liver transplant hospitalizations with Clostridium difficile infections: A 10‐year national cross‐sectional study	18
Cutaneous lesions in a solid organ transplant recipient: A diagnostic dilemma	18
	17
	16
Kidney transplantation from deceased donors with vaccine‐induced thrombosis and thrombocytopenia (VITT): Definitely feasible and safe?	16
Interesting case from Argentina: Kidney transplant recipient with skin lesions—A Latin American perspective	16
Longitudinal monitoring of BKPyV miRNA levels in kidney transplant recipients with BKPyV‐related pathology reflects viral DNA levels and remain high in viremia patients after clearance of viral DNA	16
Nosocomial disseminated fusariosis in a hematopoietic stem cell transplant recipient	16
	15
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non‐renal solid organ transplant recipients?	15
Long‐term effects of COVID‐19 in solid organ transplantation recipients	15
Perioperative anidulafungin combined with triazole prophylaxis for the prevention of early invasive candidiasis in lung transplant recipients	15
Healthcare resource utilization of maribavir versus investigator‐assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior tre	15
Impact of broad‐spectrum antibiotic exposures and multidrug‐resistant gram‐negative bacteremia on hematopoietic cell transplantation outcomes	15
Incidence of herpes zoster in adult solid organ transplant recipients: A meta‐analysis and comprehensive review	15
Vaccine protection and how we measure it	14
Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?	14
Molecular identification of Acanthamoeba genotypes isolated from oral cavity of heart transplant patients in Iran	14
Issue Information	14
Direct‐Acting Antiviral Treatment Failure and Retreatment Strategies Following Hepatitis C‐Positive Solid Organ Transplantation in Hepatitis C‐Negative Recipients: A Multicenter Case Series	13
COVID‐19 after hematopoietic cell transplantation and chimeric antigen receptor (CAR)‐T‐cell therapy	13
Infectious complications among CD19 CAR‐T cell therapy recipients: A single‐center experience	13
Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review	13
Use of hepatitis B viremic donors in kidney transplant recipients: A single center experience	13
	13
Incidence, etiology, risk factors, and outcomes of pre‐engraftment bloodstream infections after first and second allogeneic hematopoietic cell transplantation	12
Latent Tuberculosis Infection Amongst Allogeneic Hematopoietic Stem Cell Transplant Recipients: The Impact of Routine Pretransplant Review by a Transplant Infectious Diseases Physician	12
Pregnancy after CMV infection following uterus transplantation: A case report from the Dallas Uterus Transplant Study	12
Pseudomonal blepharoconjunctivitis causing neutropenic sepsis after allogeneic hematopoietic cell transplantation	12
Atypical pneumonia testing in transplant recipients	12
Viral specific T cell therapy in kidney transplant recipients – A single‐center experience	11
Cefiderocol utilization in lung transplant recipients at a single center	11
Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient	11
Clinicopathologic conference: Bloodstream infection in an allogeneic hamatopoietic cell transplant: Thinking beyond the usual	11
Hospitalizations for opportunistic infections following transplantation and associated risk factors: A national cohort study of Medicare beneficiaries	11
The adverse effects of high‐dose corticosteroid on infectious and non‐infectious sequelae in renal transplant recipients with coronavirus disease‐19 in India	11
Anal dysplasia and anal cancer in liver transplant recipients: An urgent call for action for anal cancer screening and further research	11
Disseminated Kaposi sarcoma without primary cutaneous involvement in a kidney transplant recipient	11
First report of Histoplasma capsulatum left ventricular assist device infection	10
Histoplasma capsulatum tenosynovitis: An unusual presentation in a kidney transplant recipient	10
Pediatric solid organ transplant recipients positive for severe acute respiratory syndrome coronavirus 2 pre‐transplant	10
Comparison of short‐course antibiotic therapy of 6 or less days with a longer treatment in patients with cholangitis after liver transplantation	10
Antimicrobial stewardship in solid organ transplantation—A call for action!	10
Issue Information	10
Presentation, management, and outcomes of norovirus in adult and pediatric solid organ and hematopoietic stem cell transplant recipients: A multicenter, retrospective study	10
Adopting a new approach to treat refractory or resistant viral infections in solid organ transplant recipients	10

SARS‐CoV‐2 seropositivity in renal transplant patients administered intravenous immunoglobulin	10
Managing infectious challenges in the age of molecular‐targeted therapies for adult hematological malignancies	10
Carbapenem‐resistant Serratia marcescens bloodstream infection in hematopoietic stem cell transplantation patients: Will it be the next challenge?	10
Convalescent plasma treatment for early post‐kidney transplant acquired COVID‐19	9
Comment on “Belatacept‐based immunosuppression does not confer an increased risk of BK polyomavirus‐DNAemia relative to tacrolimus‐based immunosuppression”	9
Outcome of Pneumocystis pneumonia in transplant and non‐transplant HIV‐negative immunocompromised patients	9
Issue Information	9
Thank you for our 2023 reviewers	9
The performance of bronchoalveolar lavage Aspergillus PCR testing in solid organ transplant recipients with invasive pulmonary aspergillosis	9
Clinical outcomes of lung transplant recipients with pre‐transplant Mycobacterium avium complex infection	9
	9
Evolving trends in immunosuppression use and cytomegalovirus infection risk over the past decade in kidney transplantation	9
Comment on ‘Stopping antibacterial prophylaxis in pediatric allogeneic hematopoietic cell transplantation: An internal audit’	9
A call to address penicillin allergy labels in patients with hematopoietic stem cell transplants: How to avoid rash decisions	9
Letermovir for pre‐emptive cytomegalovirus therapy after allogeneic hematopoietic cell transplantation	8
Hypothermic oxygenated machine‐perfusion fluid‐related infection in a liver transplant recipient: First case report in the literature	8
Invasive pulmonary aspergillosis in solid‐organ transplant patients in the intensive care unit	8
Cutaneous infection caused by paraconiothyrium cyclothyrioides in a renal transplant recipient	8
Sulfonamide allergy label and the risk of opportunistic infections in solid organ transplant recipients – A retrospective matched cohort study	8
Long‐term follow‐up of SARS‐CoV‐2 recovered renal transplant recipients: A single‐center experience from India	8
Daptomycin‐associated pulmonary toxicity sans eosinophilia in a hematopoietic cell transplant recipient with profound leukopenia	8
De novo emergence of SARS‐CoV‐2 spike mutations in immunosuppressed patients	8
Antibody response to mRNA SARS‐CoV‐2 vaccination in 182 patients after allogeneic hematopoietic cell transplantation	8
Pathogen‐agnostic immune biomarkers that predict infection after solid organ transplantation	8
Infections in patients with primary immunodeficiencies: Insight into infections in secondary immunodeficiency and transplantation	8
Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients	7
Frailty and Infection in Solid‐Organ Transplant Recipients	7
Safety of Once‐Weekly Dapsone for Pneumocystis jirovecii Pneumonia Prophylaxis in Kidney Transplant Recipients	7
Cellular Immunity Against BK Polyomavirus in Kidney Transplant Recipients: A Comprehensive Review	7
Confronting the Challenges of Prevention, Diagnosis, and Management of Donor‐Derived Coccidioidomycosis	7
Persistent fever after coronavirus disease 2019 in liver/kidney transplant recipient	7
Nitazoxanide for Enterocytozoon bieneusi intestinal microsporidiosis	7
Lung abscess and empyema in a heart transplant recipient from Thailand	7
COVID‐19 in heart transplant recipients: Outcomes according to vaccination status	7
Signal of safety due to adverse drug reactions induced by tacrolimus with or without azithromycin	7
Management of infectious disease syndromes in thoracic organ transplants and mechanical circulatory device recipients: a Delphi panel	7
Incidence of opportunistic viral infections in hepatitis C virus nucleic acid test negative recipients of kidneys from hepatitis C virus nucleic acid test positive donors	7
1,3‐β‐D‐glucan testing for nocardiosis in solid organ transplant recipients	7
Liver transplantation from active COVID‐19 donors: Is it ethically justifiable?	7
Recurrent Outbreak of Carbapenem‐Resistant IMP‐1‐Producing Pseudomonas aeruginosa in Kidney Transplant Recipients: The Impact of Prolonged Patient Colonization	7
Infections following chimeric antigen receptor T cell therapy: 2018–2022	7
	7
Moderate acceptance of COVID‐19 vaccination in patients pre‐ and post‐heart transplantation: Experiences from a German Transplant Centre	7
Impact of high MELD scores on CMV viremia following liver transplantation	7
Incidence of sexually transmitted infections is lower among kidney transplant recipients compared to the general population—A nationwide cohort study	7
Successful liver transplantation for hepatitis B‐related acute liver failure in a patient with active COVID‐19	7
Association of Posttransplant Circulating 25‐Hydroxyvitamin D and Late‐Onset Infections Among Kidney Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD)	7
Cytomegalovirus‐associated pseudomembranous colitis in a kidney transplant recipient	7
Effect of COVID‐19 on Pulmonary Function in Allogeneic Hematopoietic Stem Cell Transplantation Recipients	7
Disparities in Access to Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk African American Kidney Transplant Patients	7
Evaluation of clotrimazole prophylaxis on tacrolimus trough concentrations in kidney transplant recipients	7
Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection	7
Oral vancomycin for Clostridioides difficile prophylaxis in allogenic hematopoietic cell transplant	7
Epidemiology of bloodstream infections and the impact of antimicrobial resistance in pediatric hematopoietic cell transplant	7
Clinical decision making is improved by BioFire Pneumonia Plus in suspected lower respiratory tract infection after lung transplantation: Results of the prospective DBATE‐IT* study	6
Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review	6
Transmission of malaria from donors to solid organ transplant recipients: A case report and literature review	6
Outcomes Associated With Blastomycosis in Solid Organ and Hematopoietic Cell Transplant Recipients	6
Clinical effectiveness of COVID‐19 vaccination in solid organ transplant recipients	6
Risk factors of cytomegalovirus infection after pediatric liver transplantation and effectiveness of preemptive therapy	6
Perspectives on biovigilance and transmission of infection of donor origin in deceased organ donation—The evolving scenario in the United Kingdom	6
Long term outcomes of liver grafts from donors with severe acute respiratory syndrome coronavirus 2: Closing the knowledge gap	6
Humoral response to heterologous prime‐booster vaccination in heart transplant recipients aged 18–70 years primed with a viral vector SARS‐CoV‐2 vaccine	6
Minding the gap: How transplant infectious disease can help close the organ donation gap	6
A transplant recipient's pandemic perspective	6
Maribavir failure in refractory cytomegalovirus infection in a lung transplant patient on extracorporeal membrane oxygenation	6
Infectious disease consultation is effective in boosting vaccine coverage in patients awaiting kidney transplantation: A French prospective study	6
Breakthrough invasive fungal infections on isavuconazole prophylaxis in hematologic malignancy & hematopoietic stem cell transplant patients	6
Association between PIRCHE‐II scores and de novo allosensitization after reduction of immunosuppression during SARS‐CoV‐2 infection in kidney transplant recipients	6
Scedosporium endophthalmitis in a patient with second allogeneic stem cell transplantation for acute myeloid leukemia	6
Erratum	6
Voriconazole inhalation powder: A novel therapeutic alternative for invasive pulmonary fungal infections	6
Prevalence and outcomes of Clostridioides difficile infection in liver transplant recipients	6
The Utility of Interferon‐γ Release Assays in the Diagnosis of Tuberculosis in Patients With Cancer	6
Neuroinvasive West Nile virus infection in solid organ transplant recipients	6
Short‐term kidney transplant outcomes from severe acute respiratory syndrome coronavirus 2 lower respiratory tract positive donors	6
Antimicrobial stewardship for organ donors: Importance, current practice, and challenges	6
A eulogy for Dr Francisco Miguel Marty Forero	6
Use of live viral vaccines after HCT: Still a lot to learn	5
Antifungal stewardship in solid‐organ transplantation: What is needed?	5

Application of Syndromic Panels for respiratory Tract Infections in Lung Transplantation: A Critical Review on Current Evidence and Future Perspectives	5
Maribavir versus investigator assigned therapy: Exploring the exploratory	5
Posttransplant HBV Vaccine Compliance, Seroprotection, and Kinetics of Hepatitis B Surface Antibody in Thoracic Organ Transplant Recipients	5
Microscopy: Not the Lost Art!	5
Malakoplakia in kidney transplant causing severe hydronephrosis and successful treatment with antibiotics and lowering immunosuppression	5
Induction immunosuppression in kidney transplant recipients with HIV: To deplete or not to deplete?	5
The Swiss Transplant Cohort Study: Implications for Transplant Infectious Diseases Research	5
Impact of COVID‐19 monoclonal antibodies on outcomes of COVID‐19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients	5
Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high‐risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves	5
Impact of coronavirus disease 2019 monoclonal antibodies on outcomes of coronavirus disease 2019 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients	5
Investigation of donor‐derived Strongyloides stercoralis infection in multiple solid organ transplant recipients—California, Michigan, Ohio, 2022	5
Safety and value of pretransplant antibiotic allergy delabeling in a quaternary transplant center	5
	5
Antibiotics and the transplant patient: The good, the bad, and the ugly	5
Kidney transplantation from a SARS‐CoV‐2‐positive donor for the recipients with immunity after COVID‐19	5
A case report of successful kidney transplantation from a deceased donor with terminal COVID‐19‐related lung damage: Ongoing dilemma between discarding and accepting organs in COVID‐19 era!	5
Evaluation of Titer‐Proven Response Rates of Pediatric Hepatitis B‐Combination Vaccines in Adult Hematopoietic Cell Transplant Recipients	5
Could cell‐free DNA and host biomarkers assist in antimicrobial stewardship with organ transplant recipients?	5
Donor‐derived tuberculosis among solid organ transplant recipients in the United States—2008 to 2018	5
Real‐world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high‐risk donor seropositive/recipient seronegative (D+R‐) liver transplant recipients (LTxR)	5
Severe acute respiratory syndrome coronavirus 2 infection in hematopoietic stem cell transplant recipients in Mexico City	5
Issue Information	5
Anal dysplasia and anal cancer screening practices among liver transplant centers in the United States: Results of an online survey	5
Cytomegalovirus surveillance after antiviral prophylaxis in CMV mismatched transplant patients: Does recurrent cytomegalovirus DNAemia impact patient survival?	5
Evaluation of pulmonary abnormalities in recipients of hematopoietic cell transplants and cellular therapies	5
Mycoplasma hominis infections in solid organ transplant recipients: Clinical characteristics, treatment outcomes, and comparison of phenotypic and genotypic susceptibility profiles	5
Solid non‐lung organs from COVID‐19 donors in seropositive or naive recipients: Where do we stand?	5
Successful allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia and preexisting pulmonary nocardiosis	5
Issue Information	5
Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with “difficult to treat” Gram‐negative bacteria	5
De Novo Lymphocytic Choriomeningitis Virus in a Heart–Kidney Transplant Recipient	5
Evaluation of oral herpes simplex virus shedding among solid organ transplant recipients: A pilot study	5
Conference Report 33rd European Congress on Clinical Microbiology and Infectious Diseases (ECCMID): New developments in pediatric oncology infectious disease supportive care	5
Clinical presentation and outcomes of COVID‐19 following hematopoietic cell transplantation and cellular therapy	5
Cidofovir, a choice for salvage treatment of cytomegalovirus infection in patients with haploidentical hematopoietic stem cell transplantation	5
The nuts and bolts of transplant infectious disease training	5
Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era	5
Successful bilateral lung transplantation from a recent SARS‐CoV‐2 PCR positive donor	5
Incidence rate of active tuberculosis in solid organ transplant recipients: Data from a nationwide population cohort in a high‐endemic country	4
Importance of antimicrobial stewardship in solid organ transplant recipients: An ESCMID perspective	4
Impact of antimetabolite discontinuation following cytomegalovirus or BK polyoma virus infection in kidney transplant recipients	4
Impact of machine perfusion on transplant infectious diseases: New challenges and opportunities	4
Clinical characteristics and incidence of toxoplasmosis after autologous hematopoietic stem cell transplantation: A retrospective study and literature review	4
Surveillance for donor‐derived infections in Australia	4
Maximizing HIV Organ Policy Equity for transplant candidates with HIV	4
Clostridioides difficile infection in intestinal transplantation: The quest for better outcomes continues	4
Thank You for Our 2021 Reviewers	4
Effect of letermovir initiation on tacrolimus concentrations among lung transplant recipients receiving concomitant azole antifungal prophylaxis	4
Adverse events after SARS‐CoV‐2 vaccination in solid organ transplant recipients: A systematic review	4
Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients	4
Chronic hepatitis E masquerading as allograft rejection in a liver transplant recipient	4
Immunosuppression in solid organ transplant recipients with Covid‐19: More data, but still complicated	4
Hypercalcemia associated with Pneumocystis jirovecii pneumonia in lung transplant recipients: Two case reports	4
Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post‐lung transplant period: A case series and literature review	4
Dissemination and implementation science and antimicrobial stewardship in solid organ transplantation: A perspective	4
Metagenomics in infectious disease diagnostics: Toward best‐use practices to optimize actionable results	4
Issue Information	4
Serologic evaluation of vaccine preventable infections and vaccination rates in kidney transplant candidates	4
Perspectives on donor‐derived infections from the Notify Library	4
Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients	4
Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans	4
Blastomycosis in solid organ transplant recipients—A retrospective series from southeastern Wisconsin	4
Malignancy following solid organ transplantation: Current techniques for determination of donor versus recipient origin	4
COVID‐19 vaccine effectiveness in patients with hematologic malignancy	4
Interleukin‐18 and tumor necrosis factor‐α are elevated in solid organ transplant recipients with possible cytomegalovirus end‐organ disease	4
A glimpse into my journey: Lung transplantation for COVID‐19	4
A cluster of BK polyomavirus‐associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation	4
	4
Humoral and cellular response of COVID‐19 vaccine among solid organ transplant recipients: A systematic review and meta‐analysis	4
Use of letermovir for cytomegalovirus primary prophylaxis in lung transplant recipients	4
Cidofovir‐induced anterior uveitis in an allogeneic stem cell transplant recipient	4
Immune reconstitution inflammatory syndrome in a non‐HIV immunocompromised patient with Pneumocystis Jirovecii pneumonia	4
Potential donor characteristics and decisions made by organ procurement organization staff: Results of a discrete choice experiment	4
The American Association of Tissue Banks tissue donor screening for Mycobacterium tuberculosis—Recommended criteria and literature review	4
Combined assessment of Epstein–Barr virus viral capsid antigen and Epstein–Barr virus nuclear antigen‐1 serology for post‐transplant lymphoproliferative disorder risk stratification in adult solid org	4
Clinical approach to donor‐derived infection in solid organ transplant recipients	4
The shifting roles and toxicities of cellular therapies in B‐cell malignancies	4
Rapid antimicrobial resistance detection methods for bloodstream infection in solid organ transplantation: Proposed clinical guidance, unmet needs, and future directions	4
Recurrent fever 3 years post‐lung transplantation: A treacherous case of Mycobacterium genavense	4
Global perspectives on donor‐derived infections: Brazil and Argentina	4
Issue Information	4
COVID‐19 in organ donors: An organ procurement organization perspective	4
A practical guide to real‐world implementation of pre‐emptive therapy for Cytomegalovirus disease prevention in high‐risk seronegative liver transplant recipients with seropositive donors	4
Cowpox to COVID: History of vaccination in the immunocompromised host	4
Rat hepatitis E in kidney transplant recipients: Case studies and review of literature	4
The outcomes of Clostridioides difficile infection in inpatient liver transplant population	4
Issue Information	4